Andrea Richardson

Last updated
Andrea Richardson
Born1962 (age 6061)
Other namesAndrea Lynn Richardson
Alma mater University of Texas Southwestern Medical Center
Scientific career
FieldsMolecular pathology, breast cancer research
Institutions Harvard Vanguard Medical Associates
Brigham and Women's Hospital
Dana–Farber Cancer Institute
Harvard Medical School
Johns Hopkins School of Medicine
Thesis Molecular cloning and characterization of the t(2 ; 14) translocation associated with childhood CLL  (1990)
Doctoral advisor Philip W. Tucker

Andrea Lynn Richardson (born 1962) is an American pathologist and physician-scientist specialized in the molecular pathology of breast cancer. She is the Peter and Judy Kovler Professor in Breast Cancer Research and an associate professor of pathology and oncology at the Johns Hopkins School of Medicine. Richardson runs a clinic at the Sibley Memorial Hospital.

Life

Richardson was born in 1962. [1] She earned a Ph.D. and M.D. at the University of Texas Southwestern Medical Center in 1992. [2] Her dissertation was titled, Molecular cloning and characterization of the t(2 ; 14) translocation associated with childhood CLL. [1] Philip W. Tucker was her doctoral advisor. [1] She was an anatomic pathology staff member in the department of pathology and laboratory medicine at Harvard Vanguard Medical Associates from 1993 to 1997. [2] Richardson completed a residency in anatomic and clinical pathology with subspecialty training in breast cancer pathology and cytopathology at the Brigham and Women's Hospital in 1998. [2]

In 2000, joined the department of cancer biology at the Dana–Farber Cancer Institute and the department of pathology at Brigham and Women's Hospital. [2] She worked in clinical practice in the breast pathology consultation service and in the translational research laboratory where she became an associate professor of pathology at the Harvard Medical School. [2] She specializes in the molecular pathology of breast cancer. [3] In 2015, Richardson joined the Johns Hopkins School of Medicine as the director of pathology and breast pathology in its community practice division. [2] Her clinic is in the Sibley Memorial Hospital and she conducts translational breast cancer research at the Sidney Kimmel Comprehensive Cancer Center. [2] Richardson is an associate professor of pathology and oncology and the Peter and Judy Kovler Professor in Breast Cancer Research. [2]

Related Research Articles

<span class="mw-page-title-main">Anatomical pathology</span> Medical specialty

Anatomical pathology (Commonwealth) or Anatomic pathology (U.S.) is a medical specialty that is concerned with the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues. Over the last century, surgical pathology has evolved tremendously: from historical examination of whole bodies (autopsy) to a more modernized practice, centered on the diagnosis and prognosis of cancer to guide treatment decision-making in oncology. Its modern founder was the Italian scientist Giovan Battista Morgagni from Forlì.

<span class="mw-page-title-main">Sibley Memorial Hospital</span> Hospital in D.C., United States

Sibley Memorial Hospital is a non-profit hospital located in The Palisades neighborhood of Washington, D.C. It is fully accredited by the Joint Commission on Accreditation of Healthcare Organizations, and is licensed by the District of Columbia Department of Health and Human Services. The hospital specializes in surgery, orthopedics, and oncology services. It has been part of Johns Hopkins Medicine since 2010.

Martine J. Piccart-Gebhart is a Belgian medical oncologist. She is a professor of oncology at the Université Libre de Bruxelles and scientific director at the Jules Bordet Institute in Brussels, Belgium. She is also a member of the Belgian Royal Academy of Medicine.

Naoto T Ueno is a Professor of Medicine at The University of Texas MD Anderson Cancer Center; his research is in the area of inflammatory breast cancer and the molecular mechanism of metastasis and tumorigenicity. Ueno is also affiliated with the Keio University as a visiting professor.

Laura Johanna van 't Veer is a Dutch molecular biologist and clinical molecular geneticist. She is group leader molecular pathology for the Department of Pathology and Division of Experimental Therapy of The Netherlands Cancer Institute.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University is an NCI-Designated Comprehensive Cancer Center in Baltimore, MD. It was established in 1973 and received its NCI designation that same year as one of the first designated cancer centers in the country.

<span class="mw-page-title-main">Elizabeth Jaffee</span> American oncologist

Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.

Arnold B. Rabson is an American scientist and biomedical researcher. He is the director of the Child Health Institute of New Jersey and the Laura Gallagher Chair of Developmental Biology at Robert Wood Johnson Medical School. Rabson is a Fellow of the American Association for the Advancement of Science.

Ravi Salgia is a translational thoracic oncologist, clinician/scientist, and academician.

<span class="mw-page-title-main">Sarah Coupland</span> Australian clinical pathologist

Sarah Coupland is an Australian-born pathologist and professor who is the George Holt Chair in Pathology at the University of Liverpool. Coupland is an active clinical scientist whose research focuses on the molecular genetics of cancers, with particular interests in uveal melanoma, conjunctival melanoma, intraocular and ocular adnexal lymphomas and CNS lymphoma. Coupland is also an NHS Honorary Consultant Histopathologist at the Royal Liverpool University Hospital. Since 2006, Coupland has been head of the Liverpool Ocular Oncology Research Group; from which she runs a multidisciplinary oncology research group focussing on Uveal melanoma, based in the Department of Molecular and Clinical Cancer Medicine at the University of Liverpool. Her research laboratory is currently located in the Institute of Translational Medicine From April 2014 to December 2019, Coupland was also Director of the North West Cancer Research Centre, @UoL. In both 2019 and 2020, Coupland was included on the 'Pathology Powerlist' on The Pathologist website.

Cynthia Casson Morton is an American geneticist, professor at Harvard Medical School, and director of cytogenetics at Brigham and Women's Hospital.

<span class="mw-page-title-main">Jung-Min Lee</span> South Korean-American medical oncologist and physician-scientist

Jung-Min Lee is a South Korean-American medical oncologist and physician-scientist focused on the early clinical drug development and translational studies of targeted agents in BRCA mutation-associated breast or ovarian cancer, high-grade epithelial ovarian cancer, and triple-negative breast cancer. She is a NIH Lasker Clinical Research Scholar and principal investigator in the Women's Malignancies Branch at the National Cancer Institute.

Kathleen R. Cho is an American gynecological surgical pathologist. She is a Professor of Pathology and Internal Medicine at Michigan Medicine.

<span class="mw-page-title-main">Maria J. Merino</span> Spanish pathologist and physician-scientist

Maria J. Merino is a Spanish pathologist and physician-scientist. She researches tumor suppressor genes and breast cancer. Merino is chief of the translational surgical pathology section at the National Cancer Institute.

Sherene Loi is an Australian oncologist. She is the 2021 winner of the Australian Prime Ministers Prize for Science, in the category of Frank Fenner Prize for Life Scientist of the Year. Loi is Head of Translational Breast Cancer Research, within the Peter Macallum Cancer Centre. Loi's research has advanced understanding into breast cancer, developing and implementing an immune system biomarker. This biomarker will enable improved management for people with advanced cancer. This biomarker is now part of routine pathology reporting across many countries and also is included in the World Health Organisation Classification of Tumours.

Nancy Lin is an American oncologist who works at the Dana-Farber Cancer Institute and is an Associate Professor of Medicine at Harvard Medical School. Her research considers new diagnostic strategies and treatment pathways for HER2 positive breast cancer.

<span class="mw-page-title-main">Sendurai Mani</span>

Sendurai A. Mani is an Indian-American oncologist. He is a fellow of the American Association for the Advancement of Sciences and Associate Director for Legorreta Cancer Center at Alpert Medical School, Brown University. Previously, he was a co-director of Metastasis Research Center and co-director, Center for Stem Cell & Developmental Biology, and Professor of Translational Molecular Pathology at MD Anderson Cancer Center.

W. Kimryn Rathmell is an American physician-scientist whose work focuses on the research and treatment of patients with kidney cancers. She is the Hugh Jackson Morgan Professor and Chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), and Physician-in-Chief for Vanderbilt University Adult Hospital and Clinics in Nashville, Tennessee.

<span class="mw-page-title-main">Maria Teresa Landi</span>

Maria Teresa Landi is an Italian epidemiologist and oncologist who researches genetic and environmental determinants of lung cancer and melanoma. At the National Cancer Institute, she is a senior investigator in the integrative tumor epidemiology branch and a senior advisor for genomic epidemiology. Landi is an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.

Akhilesh Pandey, M.D., Ph.D., is an Indian-American proteomicist and a Professor at Department of Laboratory Medicine and Pathology, Center for Individualized Medicine of Mayo Clinic in Rochester, Minnesota, USA. He is also the founding director and chief scientific officer of the Institute of Bioinformatics in Bangalore, India.

References

  1. 1 2 3 Richardson, Andrea Lynn (1990). Molecular cloning and characterization of the t(2 ; 14) translocation associated with childhood CLL (Ph.D. thesis). University of Texas Southwestern Medical Center at Dallas. OCLC   26680128.
  2. 1 2 3 4 5 6 7 8 "Andrea Lynn Richardson, M.D., Ph.D., Associate Professor of Pathology". Johns Hopkins Medicine. Retrieved 2023-02-08.
  3. "Andrea Richardson, M.D., Ph.D." Johns Hopkins Medicine Department of Pathology. Retrieved 2023-02-07.